American Society for Reproductive Medicine, Birmingham, Alabama.
Fertil Steril. 2018 Dec;110(7):1246-1252. doi: 10.1016/j.fertnstert.2018.09.011.
The purposes of this Practice Committee Opinion, which replaces the 2013 ASRM Practice Committee Opinion of the same name (Fertil Steril 2013; 99:667-72), are to review the literature regarding the clinical application of blastocyst transfer and identify the potential risks and laboratory issues related to the use of this technology. This document does not apply to patients undergoing blastocyst culture and transfer for preimplantation genetic testing.
本实践委员会意见旨在回顾有关囊胚移植临床应用的文献,并确定与该技术使用相关的潜在风险和实验室问题。本文件不适用于因植入前遗传学检测而进行囊胚培养和移植的患者。